Effective Treatments for Jellyfish Stings

NCT ID: NCT02015195

Last Updated: 2015-04-13

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

97 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-06-30

Study Completion Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to attempt to determine which treatment from commonly used treatments is the best at reducing pain and redness of the skin after a sting from a Portuguese Man of War, Chrysaora chinensis, or Chrysaora fuscescens.

Jellyfish stings are a common occurrence in many parts of the world causing significant morbidity to persons stung by jellyfish while participating in marine activities whether commercial or recreational. Much debate and confusion exist both in the medical literature and the common recommendations regarding how to treat persons stung by jellyfish. Specifically concerning what topical treatments are most efficacious at decreasing envenomation by nematocyst on skin, preventing the firing of un-discharged nematocyst, decreasing inflammation and pain resulting from envenomation by nematocyst. Antidotal recommendations and past studies have referenced numerous different topical treatments for jellyfish stings including but not limited to vinegar, urine, alcohol, distilled spirits, ammonia, bleach, acetone, bicarbonate slurry, lidocaine, meat tenderizer, Coca Cola, old wine, salt water, cold packs, hot water, and commercial products such as Stingose and Stingaid. Conflicting data exists regarding what works and what does not for nematocysts discharge, skin erythema, and pain reaction.

The investigators would like to investigate which treatment is best out of some of the more commonly studied treatments for reducing pain and erythema.

The investigators would like to complete a research study to try to bring some reasonable evidence to the field treatment of jellyfish stings, namely, the decontamination process (e.g., what can you put on a jellyfish sting that will be helpful, based on real data?).

The questions asked are as follows:

* What topical treatments for jellyfish stings actually decrease the amount of inflammation seen on a macroscopic level on the skin of humans?
* What topical treatments for jellyfish stings actually decrease the sensation of pain in humans?
* Do topical chemical treatments cause different outcomes when exposed to the above parameters?
* Do different species of jellyfish nematocysts react differently based on the type of topical chemical treatment used? What is the variation of effects of topical treatments based on the species of jellyfish sting?

Specifically, the investigators will be stinging human subject on both arms with a segment of tentacle for approximately 2 minutes. This will be followed by no treatment on one arm (control arm) and by treatment on the other arm with either: acetic acid (5%), sodium bicarbonate slurry (50%), papain slurry (70%), ammonia (10%), viscous lidocaine (4%), isopropyl alcohol (70%), or hot tap water (40 degrees Celsius). Outcomes measured will include pain and erythema.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Jellyfish Stings

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Acetic Acid 5%

Acetic Acid (5%) Dosage form: Liquid Dosage: 5 ml topical Frequency: every 2 minutes Duration: 30 minutes

Group Type EXPERIMENTAL

Acetic Acid (5%)

Intervention Type OTHER

No treatment

Intervention Type OTHER

Sodium Bicarbonate Slurry (50%)

Sodium Bicarbonate Slurry (50%) Dosage form: Liquid slurry Dosage: 5 ml topical Frequency: every 2 minutes Duration: 30 minutes

Group Type EXPERIMENTAL

Sodium Bicarbonate Slurry (50%)

Intervention Type OTHER

No treatment

Intervention Type OTHER

Papain Slurry (70%)

Papain Slurry (70%) Dosage form: Liquid slurry Dosage: 5 ml topical Frequency: every 2 minutes Duration: 30 minutes

Group Type EXPERIMENTAL

Papain Slurry (70%)

Intervention Type OTHER

No treatment

Intervention Type OTHER

Household ammonia (10%)

Ammonia (10%) Dosage form: Liquid Dosage: 5 ml topical Frequency: every 2 minutes Duration: 30 minutes

Group Type EXPERIMENTAL

Ammonia (10%)

Intervention Type OTHER

No treatment

Intervention Type OTHER

Lidocaine (4%)

Lidocaine (4%) Dosage form: Liquid Dosage: 5 ml topical Frequency: every 2 minutes Duration: 30 minutes

Group Type EXPERIMENTAL

Lidocaine (4%)

Intervention Type DRUG

No treatment

Intervention Type OTHER

Isopropyl Alcohol (70%)

Isopropyl Alcohol (70%) Dosage form: Liquid Dosage: 5 ml topical Frequency: every 2 minutes Duration: 30 minutes

Group Type EXPERIMENTAL

Isopropyl Alcohol (70%)

Intervention Type OTHER

No treatment

Intervention Type OTHER

Hot Water (40 degrees Celsius)

Hot Tap Water (40 degrees Celsius) Dosage form: Liquid Dosage: 5 ml topical Frequency: every 2 minutes Duration: 30 minutes

Group Type EXPERIMENTAL

Hot Tap Water (40 degrees Celsius)

Intervention Type OTHER

No treatment

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Acetic Acid (5%)

Intervention Type OTHER

Sodium Bicarbonate Slurry (50%)

Intervention Type OTHER

Papain Slurry (70%)

Intervention Type OTHER

Ammonia (10%)

Intervention Type OTHER

Lidocaine (4%)

Intervention Type DRUG

Isopropyl Alcohol (70%)

Intervention Type OTHER

Hot Tap Water (40 degrees Celsius)

Intervention Type OTHER

No treatment

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Vinegar Adolfo's Meat tenderizer Household ammonia Liquid Lidocaine Rubbing alcohol Hot Water Nothing is given topically to treat sting. This is the control.

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ages 18-65 years
* Healthy volunteers

Exclusion Criteria

* Known history of allergic reaction or anaphylaxis to prior Cnidaria sting of there envenomations
* Family history of anaphylaxis to any sting from either Cnidaria, bee, or wasp
* Pregnancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Stanford University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Paul S Auerbach

Principle Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paul S Auerbach, MD

Role: PRINCIPAL_INVESTIGATOR

Division of Emergency Medicine, Stanford University Medical Center

Matthieu P DeClerck, MD

Role: STUDY_DIRECTOR

Division of Emergency Medicine, Stanford University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Stanford University Medical Center

Palo Alto, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

JSP-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cryotherapy as a Topical Anesthetic in Healthy Children
NCT07198022 ACTIVE_NOT_RECRUITING PHASE4
Intranasal Ketamine as a Sedative for Venipuncture
NCT02929524 COMPLETED PHASE2/PHASE3
Topical Radial Artery Vasodilation
NCT01155167 COMPLETED PHASE2/PHASE3